NCT03213951 - Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection and Evaluation of PSMA-PET for Diagnosis of Intraprostatic Lesions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 18, 2017

Primary Completion Date

November 13, 2019

Study Completion Date

November 13, 2019

Conditions

Prostate Cancer

Interventions

OTHER

Experimental beta probe

3mCi (or similar) dose of 68Ga-PSMA-11 will be given prior to resection of cancer. Experimental beta probe designed to detect 68Ga-PSMA-11 will be used on prostate tissue after it has been surgically removed.

DIAGNOSTIC_TEST

PSMA-PET

PSMA-PET imaging done prior to surgery and compared to whole mount imaging.

Trial Locations (2)

46202

Indiana University Health Hospital, Indianapolis

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis